Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1166588 NEW YORK, NY

Position in BTAI

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$79
+$60 QoQ
Shares Held
59
+391.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 40 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $498,843,244 across 54 Drug Manufacturers - Specialty & Generic names. BTAI ranks #53 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $79 59
2025-12-31 $19 12
2025-09-30 $99 39
2025-06-30 $79 44
2025-03-31 $89 44